Acetic acid

Repeated dose toxicity: dermal

Administrative data

Endpoint:

chronic toxicity: dermal

Type of information:

experimental study

Adequacy of study:

supporting study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Non- GLP, non- guideline study, published in peer reviewed literature. No restrictions, fully adequate for assessment.

Cross-reference

Reason / purpose for cross-reference:

reference to same study

Data source

Reference

Reference Type:

publication

Title:

Acetic acid, a potent stimulator of mouse epidermal macromolecular synthesis and hyperplasia but with weak tumour-promoting ability

Author:

Slaga T, Bowden G & Boutwell R

Year:

1975

Bibliographic source:

Nat. Cancer Inst., Vol 55, pp 983-987

Materials and methods

Test guideline

Qualifier:

no guideline available

Principles of method if other than guideline:

Acetic acid was used as a promotor for tumour development in mice initiated with DMBA or β-PL and was applied dermally 1-3 times per week (at doses of 1-40 mg/animal) for 32 weeks. Control animals received acetic acid dermally once per week. The incidence of papillomas and carcinomas was recorded and they were removed at random for histological verification.

GLP compliance:

no

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

Acetic acid

EC Number:

200-580-7

EC Name:

Acetic acid

Cas Number:

64-19-7

Molecular formula:

C2H4O2

IUPAC Name:

acetic acid

Details on test material:

- Name of test material (as cited in study report): Acetic acid
- Analytical purity: Not reported
- No details reported

Test animals

Species:

mouse

Strain:

CD-1

Sex:

female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Charles River Mouse Farms, North Wilmington, Massachusetts, USA
- Age at study initiation: 7-12 weeks old
- Weight at study initiation: not reported
- Housing: not reported
- Diet (e.g. ad libitum): not reported
- Water (e.g. ad libitum): not reported

Administration / exposure

Type of coverage:

not specified

Vehicle:

acetone

Details on exposure:

TEST SITE
- Area of exposure: No details reported
- % coverage: No details reported
- Type of wrap if used: No details reported
- Time intervals for shavings or clippings: shaved 2 days before exposure

REMOVAL OF TEST SUBSTANCE
- no details reported

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.2 mL in acetone
- Concentration (if solution): 33, 167, 333, 500, 667, 833 or 1000 μmoles/animal
- Constant volume or concentration used: yes

VEHICLE
- Justification for use and choice of vehicle (if other than water): No details reported
- Amount(s) applied (volume or weight with unit): 0.2 mL

USE OF RESTRAINERS FOR PREVENTING INGESTION: no details

Analytical verification of doses or concentrations:

not specified

Duration of treatment / exposure:

32 weeks

Frequency of treatment:

1-3 times per week.
Controls dosed once per week.

Doses / concentrations

Doses / concentrations 1

Remarks:

Doses / Concentrations:
0, 1. 2, 10, 20, 40 mg/animal
Basis:

Doses / concentrations 2

Remarks:

Doses / Concentrations:
0, 17, 33, 167, 333, 667 μmoles
Basis:

No. of animals per sex per dose:

20-30

Control animals:

yes, sham-exposed

Positive control:

0.25% croton oil

Examinations

Observations and examinations performed and frequency:

The animals were observed and the incidence of papillomas and carcinomas was recorded weekly

Sacrifice and pathology:

GROSS PATHOLOGY: No data
HISTOPATHOLOGY: Yes - during the 32 week study, papillomas and carcinomas were removed for histological verification at random

Results and discussion

Results of examinations

Clinical signs:

effects observed, treatment-related

Mortality:

mortality observed, treatment-related

Details on results:

Mortality:
- A single dermal application of acetic acid at doses of up to 40 mg/animal, in mice initiated with ß-PL or DMBA did not induce excessive mortality. However, more than one weekly application of 10-40 mg acetic acid caused excessive mortality. 33% of mice died when 10 mg acetic acid/animal was applied dermally 3 times per week and approximately 50% of mice died when 20 mg was applied twice a week.

Effect levels

1

Dose descriptor:

NOAEL

Remarks:

toxicity

Effect level:

30 other: mg/animal

Sex:

female

Basis for effect level:

other: No deaths when applied dermally once per week for 32 weeks

2

Dose descriptor:

LOAEL

Remarks:

toxicity

Effect level:

10 other: mg/animal

Sex:

female

Basis for effect level:

other: Mortality (33%) when applied dermally 3 times per week.

Target system / organ toxicity

Critical effects observed:

not specified

Applicant's summary and conclusion

Executive summary:

Acetic acid was used as a promotor for tumour development in mice initiated with DMBA or β-PL and was applied dermally 1-3 times per week (at doses of 1-40 mg/animal) for 32 weeks. Control animals received acetic acid dermally once per week.

A single dermal application of acetic acid at doses of up to 40 mg/animal, in mice initiated with ß-PL or DMBA did not induce excessive mortality. However, more than one weekly application of 10 -40 mg acetic acid caused excessive mortality. 33% of mice died when 10 mg acetic acid/animal was applied dermally 3 times per week and approximately 50% of mice died when 20 mg was applied twice a week.